Rate My Professor Mary Bebawy

Professor Bebawy's academic interests center on pharmacy and cancer research, specifically investigating extracellular vesicle biogenesis, intercellular transfer of drug resistance mechanisms, and their implications for cancer therapy. Her influential publications include "Circulating biosignatures in multiple myeloma and their role in multidrug resistance" (2023), "Membrane to cytosol redistribution of αII-spectrin drives extracellular vesicle biogenesis in malignant breast cells" (2021), "Extracellular Vesicles in Chemoresistance" (2021), "Ca2+ mediates extracellular vesicle biogenesis through alternate pathways in malignancy" (2020), "Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion" (2017), "A novel method to detect translation of membrane proteins following microvesicle intercellular transfer of nucleic acids" (2016), "Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells" (2014), and the seminal "Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells" (2009). She co-authored the MISEV2018 guidelines on extracellular vesicles. Additionally, she chairs the School of Health Research Committee at UNE and was shortlisted for the 2017 Lush Prize Creative Scientist award.